IRD OPUS GENETICS INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Wed 11 Nov 2026 · estimated
What 21 analyst firms say about OPUS GENETICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
21 rated views · 22 analyst/firm records · 21 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 15 reports on IRD from 13 analyst firms in the last 90 days (22 firms in the past year).
Comparing each firm's latest target with its previous one: 5 raised their price target, 3 left it unchanged and 3 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Citizens raised its target from $11.00 (set 15 Jun 2026) to $17.00 on 16 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Alliance Global Partners | James Molloy | Buy | 1 Jul 2026 | 9.00 USD |
| B Riley Securities | Madison El-Saadi | Buy | 9 Aug 2026 | 10.00 USD |
| Brookline Capital Markets | Kumaraguru Raja | Buy | 9 Sep 2026 | 11.00 USD |
| BTIG | Thomas Shrader | Buy | 9 Sep 2026 | 12.00 USD |
| Cantor Fitzgerald | Steve Seedhouse | Buy | 10 Jul 2026 | 15.00 USD |
| Chardan Capital Markets | Andreas Argyrides | Buy | 22 Oct 2026 | 16.00 USD |
| Citigroup | Unnamed analyst | Buy | 28 Apr 2026 | — |
| Citizens JMP | Jonathan Wolleben | Buy | 16 Oct 2026 | 17.00 USD |
| Craig-Hallum | Albert Love | Buy | 11 Mar 2026 | 9.00 USD |
| Craig-Hallum | Albert Lowe | Buy | 11 Mar 2026 | 9.00 USD |
| Guggenheim | Debjit Chattopadhyay | Buy | 4 Jun 2026 | 16.00 USD |
| H.C. Wainwright | Matthew Caufield | Buy | 9 Sep 2026 | 8.00 USD |
| Jonestrading | Debanjana Chatterjee | Buy | 6 Oct 2026 | 17.00 USD |
| Leerink Partners | Lili Nsongo | Buy | 9 Sep 2026 | 14.00 USD |
| Lifesci Capital | Francois Brisebois | Buy | 12 Sep 2026 | 10.00 USD |
| Lucid Capital Markets | Dev Prasad | Buy | 6 Jul 2026 | 8.00 USD |
| Piper Sandler | Biren Amin | Buy | 6 Aug 2026 | 7.00 USD · 25 Nov 2025 |
| RBC Capital Markets | Lisa Walter | Buy | 7 Aug 2026 | 9.00 USD |
| TD Cowen | Ritu Baral | Buy | 29 Jul 2026 | — |
| Wedbush | Yun Zhong | Buy | 10 Sep 2026 | 13.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 11 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:59 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.